What is Sonavex?
Sonavex is at the forefront of medical technology, developing automated 3D ultrasound solutions designed to improve patient outcomes in dialysis access. Their product suite, including EchoMark, EchoSure, and EchoMap, offers real-time visualization and monitoring of blood flow, crucial for effective fistula maturation and precise cannulation guidance. By integrating clinical and economic value through sophisticated technology, Sonavex aims to optimize healthcare delivery and patient well-being. The company's commitment to data-driven insights and a multidisciplinary approach positions it as a key player in the medtech sector, addressing critical needs in vascular access management.
How much funding has Sonavex raised?
Sonavex has raised a total of $9.3M across 6 funding rounds:
Angel/Seed
$1M
Private Equity
$2.2M
Grant
$750K
Series A
$2.2M
Unspecified
$3M
Debt
$150K
Angel/Seed (2015): $1M, investors not publicly disclosed
Private Equity (2016): $2.2M, investors not publicly disclosed
Grant (2017): $750K supported by National Science Foundation
Series A (2017): $2.2M featuring CRCM Venture Capital, Grey Sky Venture Partners, the Abell Foundation, and Maryland Technology Development
Unspecified (2019): $3M backed by Texas Medical Center
Debt (2020): $150K with participation from PPP
Key Investors in Sonavex
CRCM Venture Capital
CRCM Venture Capital is a registered investment adviser based in San Francisco, focusing on tailored financial strategies. Their expertise is aimed at individuals and institutions seeking professional investment management.
Grey Sky Venture Partners
Grey Sky Venture Partners specializes in providing comprehensive tools for planning and executing large-scale cruise events, catering to clients organizing corporate retreats, weddings, and other group celebrations at sea.
Maryland Technology Development
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland.
What's next for Sonavex?
With the recent influx of major strategic investment, Sonavex is poised for accelerated expansion and product development. The company's focus on enhancing patient care through advanced ultrasound technology aligns with the growing demand for innovative medical devices in chronic care management. Future endeavors will likely involve scaling production, expanding market reach to new healthcare systems, and potentially exploring new applications for their core technology. This capital infusion will be instrumental in solidifying Sonavex's position as a leader in automated ultrasound solutions, driving advancements in patient safety and treatment efficacy within the dialysis and vascular access markets.
See full Sonavex company page
